comparemela.com

Latest Breaking News On - Stephens consulting - Page 8 : comparemela.com

Citizens Financial Group Inc RI Increases Holdings in NIKE, Inc (NYSE:NKE)

Citizens Financial Group Inc. RI lifted its holdings in NIKE, Inc. (NYSE:NKE – Free Report) by 4.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 70,154 shares of the footwear maker’s stock after purchasing an additional 3,052 shares during the quarter. […]

Mogy Joel R Investment Counsel Inc Has $13 65 Million Position in NIKE, Inc (NYSE:NKE)

Mogy Joel R Investment Counsel Inc. lowered its holdings in NIKE, Inc. (NYSE:NKE – Free Report) by 0.9% in the 4th quarter, HoldingsChannel.com reports. The firm owned 125,704 shares of the footwear maker’s stock after selling 1,130 shares during the quarter. NIKE accounts for about 1.0% of Mogy Joel R Investment Counsel Inc.’s holdings, making […]

Private Wealth Partners LLC Raises Holdings in NIKE, Inc (NYSE:NKE)

Private Wealth Partners LLC Raises Holdings in NIKE, Inc (NYSE:NKE)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

2,065 Shares in iShares Russell 2000 Value ETF (NYSEARCA:IWN) Purchased by Linden Thomas Advisory Services LLC

Linden Thomas Advisory Services LLC purchased a new stake in shares of iShares Russell 2000 Value ETF (NYSEARCA:IWN – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 2,065 shares of the company’s stock, valued at approximately $321,000. Several other hedge funds and […]

Apellis Pharmaceuticals (NASDAQ:APLS) Given Buy Rating at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) in a report released on Friday, Benzinga reports. The firm currently has a $92.00 target price on the stock. Other equities research analysts have also recently issued research reports about the company. UBS Group upped their target price on Apellis […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.